View More View Less
  • 1 Honvédkórház-Állami Egészségügyi Központ II. Belgyógyászati Osztály, Endokrinológiai Szakprofil Budapest Podmaniczky u. 111. 1062
  • 2 Országos Idegtudományi Intézet Budapest
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $1,070.00

2009 áprilisában az Acromegaly Consensus Group összefoglalta azokat a legújabb eredményeket, amelyek alapján szükségessé vált az acromegalia aktivitását jelző kritériumok változtatása. Az eredmények értékelésében 74 tapasztalt idegsebész és endokrinológus vett részt. A konszenzuskritériumok összeállítása során elemezték a növekedési hormon és inzulinszerű növekedési faktor-1 assay-k megbízhatóságát, valamint a növekedési hormon és az inzulinszerű növekedési faktor-1 szerepét az acromegalia aktivitásának megítélésében. Véleményt alkottak az egymásnak ellentmondó növekedési hormon és inzulinszerű növekedési faktor-1 eredmények megítéléséről. Leírták az acromegalia gyógyulását meghatározó kritériumokat, illetve a gyógyulást elősegítő evidenciákon alapuló terápiás lépéseket. Az összefoglaló a klinikum számára legfontosabb megállapításokat ismerteti. Orv. Hetil., 2011, 152, 703–708.

  • Barkan, A. és mtsai: Guidelines for acromegaly management: an update. J. Clin. Endocrinol. Metab., 2009, 94, 1509–1517.

    Barkan A. , 'Guidelines for acromegaly management: an update ' (2009 ) 94 J. Clin. Endocrinol. Metab. : 1509 -1517.

    • Search Google Scholar
  • Giustina, A., Chanson, P., Bronstein, M. D. és mtsai: A consensus criteria for cure of acromegaly. J. Clin. Endocrinol. Metab., 2010, 95, 3141–3148.

    Bronstein M. D. , 'A consensus criteria for cure of acromegaly ' (2010 ) 95 J. Clin. Endocrinol. Metab. : 3141 -3148.

    • Search Google Scholar
  • Bidlingmaier, M.: Problems with GH assays and strategies toward standardization. Eur. J. Endocrinol., 2008, 159, S41–S44.

    Bidlingmaier M. , 'Problems with GH assays and strategies toward standardization ' (2008 ) 159 Eur. J. Endocrinol. : S41 -S44.

    • Search Google Scholar
  • Massart, C., Poirier, J. Y.: Serum insulin-like growth factor-1 measurement in the follow-up of treated acromegaly: comparison of four immunoassays. Clin. Chem. Acta, 2006, 373, 176–179.

    Poirier J. Y. , 'Serum insulin-like growth factor-1 measurement in the follow-up of treated acromegaly: comparison of four immunoassays ' (2006 ) 373 Clin. Chem. Acta : 176 -179.

    • Search Google Scholar
  • Trainer, P. J., Barth, J., Sturgeon, C. és mtsa: Consensus statement on standardisation of GH assays. Eur. J. Endocrinol., 2006, 155, 1–2.

    Sturgeon C. , 'Consensus statement on standardisation of GH assays ' (2006 ) 155 Eur. J. Endocrinol. : 1 -2.

    • Search Google Scholar
  • Burns, C., Rigsby, P., Moore, M. és mtsa: The first international standard for insulin-like growth factor-1 (IGF-1) for immunoassay: preparation and calibration in an international collaborative study. Growth Horm. IGF Res., 2009, 19, 457–462.

    Moore M. , 'The first international standard for insulin-like growth factor-1 (IGF-1) for immunoassay: preparation and calibration in an international collaborative study ' (2009 ) 19 Growth Horm. IGF Res. : 457 -462.

    • Search Google Scholar
  • Arosio, M., Garrone, S., Bruzzi, P. és mtsai: Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) -1, and IGF-binding protein -1, -2, and -3. J. Clin. Endocrinol. Metab., 2001, 86, 1091–1098.

    Bruzzi P. , 'Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) -1, and IGF-binding protein -1, -2, and -3 ' (2001 ) 86 J. Clin. Endocrinol. Metab. : 1091 -1098.

    • Search Google Scholar
  • Barkan, A. L., Dimaraki, E. V., Jessup, S. K. és mtsai: Ghrelin secretion in humans is sexually dimorphic, suppressed by somatostatin, and not affected by the ambient growth hormone levels. J. Clin. Endocrinol. Metab., 2003, 88, 2180–2184.

    Jessup S. K. , 'Ghrelin secretion in humans is sexually dimorphic, suppressed by somatostatin, and not affected by the ambient growth hormone levels ' (2003 ) 88 J. Clin. Endocrinol. Metab. : 2180 -2184.

    • Search Google Scholar
  • Clemmons, D. R.: Value of insulin-like growth factor system markers in the assessment of growth hormone status. Endocrinol. Metab. Clin. North. Am., 2007, 36, 109–129.

    Clemmons D. R. , 'Value of insulin-like growth factor system markers in the assessment of growth hormone status ' (2007 ) 36 Endocrinol. Metab. Clin. North. Am. : 109 -129.

    • Search Google Scholar
  • Arafat, A. M., Möhlig, M., Weickert M. O. és mtsai: Growth hormone response during oral glucose tolerance test: the impact of assay method on estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index. J. Clin. Endocrinol. Metab., 2008, 93, 1254–1262.

    Weickert M. O. , 'Growth hormone response during oral glucose tolerance test: the impact of assay method on estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index ' (2008 ) 93 J. Clin. Endocrinol. Metab. : 1254 -1262.

    • Search Google Scholar
  • Carmichael, J. D., Bonert, V. S., Mirocha, J. M. és mtsa: The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly. J. Clin. Endocrinol. Metab., 2009, 94, 523–527.

    Mirocha J. M. , 'The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly ' (2009 ) 94 J. Clin. Endocrinol. Metab. : 523 -527.

    • Search Google Scholar
  • Trainer, P. J., Drake, W. M., Katznelson, L. és mtsai: Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N. Eng. J. Med., 2000, 342, 1171–1177.

    Katznelson L. , 'Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant ' (2000 ) 342 N. Eng. J. Med. : 1171 -1177.

    • Search Google Scholar
  • Alexopoulou, O., Bex, M., Abs, R. és mtsai: Divergence between growth hormone and insulin-like growth factor-1 concentrations in the follow-up of acromegaly. J. Clin. Endocrinol. Metab., 2008, 93, 1324–1330.

    Abs R. , 'Divergence between growth hormone and insulin-like growth factor-1 concentrations in the follow-up of acromegaly ' (2008 ) 93 J. Clin. Endocrinol. Metab. : 1324 -1330.

    • Search Google Scholar
  • Freda, P. U.: Monitoring of acromegaly: what should be performed when GH and IGF-1 levels are discrepant? Clin. Endocrinol. (Oxf), 2009, 71, 166–170.

    Freda P. U. , 'Monitoring of acromegaly: what should be performed when GH and IGF-1 levels are discrepant? ' (2009 ) 71 Clin. Endocrinol. (Oxf) : 166 -170.

    • Search Google Scholar
  • Van der Klaauw, A. A., Pereira, A. M., van Thiel, S. W. és mtsai: Attenuated pulse size, disorderly growth hormone and prolactin secretion with preserved nyctohemeral rhythm distinguish irradiated from surgically treated acromegaly patients. Clin. Endocrinol. (Oxf), 2007, 66, 489–498.

    Thiel S. W. , 'Attenuated pulse size, disorderly growth hormone and prolactin secretion with preserved nyctohemeral rhythm distinguish irradiated from surgically treated acromegaly patients ' (2007 ) 66 Clin. Endocrinol. (Oxf) : 489 -498.

    • Search Google Scholar
  • Feelders, R. A., Bidlingmaier, M., Strasburger, C. J. és mtsai: Postoperative evaluation of patient with acromegaly: clinical significance and timing of oral glucose tolerance testing and measurement of (free) insulin-like growth factor 1, acid-labile subunit, and growth hormone-binding protein levels. J. Clin. Endocrinol. Metab., 2005, 90, 6480–6489.

    Strasburger C. J. , 'Postoperative evaluation of patient with acromegaly: clinical significance and timing of oral glucose tolerance testing and measurement of (free) insulin-like growth factor 1, acid-labile subunit, and growth hormone-binding protein levels ' (2005 ) 90 J. Clin. Endocrinol. Metab. : 6480 -6489.

    • Search Google Scholar
  • Minuto, F., Resmini, E., Boschetti, M. és mtsai: Assessment of diseases activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system. Clin. Endocrinol. (Oxf), 2004, 61, 138–144.

    Boschetti M. , 'Assessment of diseases activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system ' (2004 ) 61 Clin. Endocrinol. (Oxf) : 138 -144.

    • Search Google Scholar
  • Ho, K. Y., Weissberger, A. J.: Characterization of 24-hour growth hormone secretion in acromegaly: implications for diagnosis and therapy. Clin. Endocrinol. (Oxf), 1994, 41, 75–83.

    Weissberger A. J. , 'Characterization of 24-hour growth hormone secretion in acromegaly: implications for diagnosis and therapy ' (1994 ) 41 Clin. Endocrinol. (Oxf) : 75 -83.

    • Search Google Scholar
  • Prudder, J. J., Nilavar, S., Post, K. D. és mtsa: Relationship between disease-related morbidity and biochemical markers of activity in patients with acromegaly. J. Clin. Endocrinol. Metab., 2005, 90, 1972–1978.

    Post K. D. , 'Relationship between disease-related morbidity and biochemical markers of activity in patients with acromegaly ' (2005 ) 90 J. Clin. Endocrinol. Metab. : 1972 -1978.

    • Search Google Scholar
  • Dekkers, O. M., Biermasz, N. R., Pereira, A. M. és mtsai: Mortality in acromegaly: a metaanalysis. J. Clin. Endocrinol. Metab., 2008, 93, 61–67.

    Pereira A. M. , 'Mortality in acromegaly: a metaanalysis ' (2008 ) 93 J. Clin. Endocrinol. Metab. : 61 -67.

    • Search Google Scholar
  • Bogazzi, F., Battolla, L., Spinelli, C. és mtsai: Risk factors for development of coronary heart disease in patients with acromegaly: a five year prospective study. J. Clin. Endocrinol. Metab., 2007, 92, 4271–4277.

    Spinelli C. , 'Risk factors for development of coronary heart disease in patients with acromegaly: a five year prospective study ' (2007 ) 92 J. Clin. Endocrinol. Metab. : 4271 -4277.

    • Search Google Scholar
  • Bogazzi, F., Cosci, C., Sardella, C. és mtsai: Identification of acromegalic patients at risk of developing colonic adenomas. J. Clin. Endocrinol. Metab., 2006, 91, 1351–1356.

    Sardella C. , 'Identification of acromegalic patients at risk of developing colonic adenomas ' (2006 ) 91 J. Clin. Endocrinol. Metab. : 1351 -1356.

    • Search Google Scholar
  • Bonadonna, S., Mazziotti, G., Nuzzo, M. és mtsai: Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. J. Bone Miner. Res., 2005, 20, 1837–1844.

    Nuzzo M. , 'Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women ' (2005 ) 20 J. Bone Miner. Res. : 1837 -1844.

    • Search Google Scholar
  • Coculescu, M., Niculescu, D., Lichiardopol, R. és mtsa: Insulin resistance and insulin secretion in non-diabetic acromegalic patients. Exp. Clin. Endocrinol. Diabetes, 2007, 115, 308–316.

    Lichiardopol R. , 'Insulin resistance and insulin secretion in non-diabetic acromegalic patients ' (2007 ) 115 Exp. Clin. Endocrinol. Diabetes : 308 -316.

    • Search Google Scholar
  • Nemes, A., Gavallér, H., Csajbók, E. és mtsai: Aortic stiffness is increased in acromegaly: a transthoracic echocardiographic study. Int. J. Cardiol., 2008, 124, 121–123.

    Csajbók E. , 'Aortic stiffness is increased in acromegaly: a transthoracic echocardiographic study ' (2008 ) 124 Int. J. Cardiol. : 121 -123.

    • Search Google Scholar
  • Mazziotti, G., Bianchi, A., Bonadonna, S. és mtsai: Prevalence of vertebral fractures in men with acromegaly. J. Clin. Endocrinol. Metab., 2008, 93, 4649–4655.

    Bonadonna S. , 'Prevalence of vertebral fractures in men with acromegaly ' (2008 ) 93 J. Clin. Endocrinol. Metab. : 4649 -4655.

    • Search Google Scholar
  • Holdaway, I. M., Rajasoorya, C. R., Gamble, G. D. és mtsa: Long-term treatment outcome in acromegaly. Growth Horm. IGF Res., 2003, 13, 185–192.

    Gamble G. D. , 'Long-term treatment outcome in acromegaly ' (2003 ) 13 Growth Horm. IGF Res. : 185 -192.

    • Search Google Scholar
  • Davi, M. V., Dalle Carbonare, L., Giustina, A. és mtsai: Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease. Eur. J. Endocrinol., 2008, 159, 533–540.

    Giustina A. , 'Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease ' (2008 ) 159 Eur. J. Endocrinol. : 533 -540.

    • Search Google Scholar
  • Jenkins, P. J., Fairclough, P. D.: Screening guidelines for colorectal cancer and polyps in patients with acromegaly. Gut, 2002, 51, V13–V14.

    Fairclough P. D. , 'Screening guidelines for colorectal cancer and polyps in patients with acromegaly ' (2002 ) 51 Gut : V13 -V14.

    • Search Google Scholar
  • Beauregard, C., Truong, U., Hardy, J. és mtsa: Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly. Clin. Endocrinol. (Oxf), 2003, 58, 86–91.

    Hardy J. , 'Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly ' (2003 ) 58 Clin. Endocrinol. (Oxf) : 86 -91.

    • Search Google Scholar
  • Shimon, I., Cohen, Z. R., Ram, Z. és mtsa: Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients. Neurosurgery, 2001, 48, 1239–1245.

    Ram Z. , 'Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients ' (2001 ) 48 Neurosurgery : 1239 -1245.

    • Search Google Scholar
  • Attanasio, R., Lanzi, R., Losa, M. és mtsai: Effects of lanreotide Autogel on growth hormone, insulin like growth factor 1, and tumor size in acromegaly: a 1-year prospective multicenter study. Endocr. Pract., 2008, 14, 1244–1245.

    Losa M. , 'Effects of lanreotide Autogel on growth hormone, insulin like growth factor 1, and tumor size in acromegaly: a 1-year prospective multicenter study ' (2008 ) 14 Endocr. Pract. : 1244 -1245.

    • Search Google Scholar
  • Colao, A., Pivonello, R., Auriemma, R. S. és mtsai: Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: a prospective study in 99 patients. J. Clin. Endocrinol. Metab., 2006, 91, 2112–2118.

    Auriemma R. S. , 'Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: a prospective study in 99 patients ' (2006 ) 91 J. Clin. Endocrinol. Metab. : 2112 -2118.

    • Search Google Scholar
  • Colao, A., Pivonello, R., Auriemma, R. S. és mtsai: Growth hormone-secreting tumor shrinkage after 3 month of octreotide-long-acting release therapy predicts the response at 12 months. J. Clin. Endocrinol. Metab., 2008, 93, 3436–3442.

    Auriemma R. S. , 'Growth hormone-secreting tumor shrinkage after 3 month of octreotide-long-acting release therapy predicts the response at 12 months ' (2008 ) 93 J. Clin. Endocrinol. Metab. : 3436 -3442.

    • Search Google Scholar
  • Amato, G., Mazziotti, G., Rotondi, M. és mtsai: Long-term effects of lanreotide SR and octreotid LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly. Clin. Endocrinol. (Oxf), 2002, 56, 65–71.

    Rotondi M. , 'Long-term effects of lanreotide SR and octreotid LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly ' (2002 ) 56 Clin. Endocrinol. (Oxf) : 65 -71.

    • Search Google Scholar
  • Abe, T., Lüdecke, D. K.: Effects of preoperative octreotide treatment on different subtypes of 90 GH-secreting pituitary adenomas and outcome in one surgical centre. Eur. J. Endocrinol., 2001, 145, 137–145.

    Lüdecke D. K. , 'Effects of preoperative octreotide treatment on different subtypes of 90 GH-secreting pituitary adenomas and outcome in one surgical centre ' (2001 ) 145 Eur. J. Endocrinol. : 137 -145.

    • Search Google Scholar
  • Carlsen, S. M., Lund-Johansen, M., Schreiner, T. és mtsai: Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: a prospective, randomized trial. J. Clin. Endocrinol. Metab., 2008, 93, 2984–2990.

    Schreiner T. , 'Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: a prospective, randomized trial ' (2008 ) 93 J. Clin. Endocrinol. Metab. : 2984 -2990.

    • Search Google Scholar
  • Karavitaki, N., Turner, H. E., Adams, C. B. és mtsai: Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide. Clin. Endocrinol. (Oxf), 2008, 68, 970–975.

    Adams C. B. , 'Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide ' (2008 ) 68 Clin. Endocrinol. (Oxf) : 970 -975.

    • Search Google Scholar
  • Freda, P. U., Post, K. D., Powell, J. S. és mtsai: Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly. J. Clin. Endocrinol. Metab., 1998, 83, 3808–3816.

    Powell J. S. , 'Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly ' (1998 ) 83 J. Clin. Endocrinol. Metab. : 3808 -3816.

    • Search Google Scholar
  • Freda, P. U.: Monitoring of acromegaly: what should be performed when GH and IGF-1 levels are discrepant? Clin. Endocrinol. (Oxf), 2009, 71, 166–170.

    Freda P. U. , 'Monitoring of acromegaly: what should be performed when GH and IGF-1 levels are discrepant? ' (2009 ) 71 Clin. Endocrinol. (Oxf) : 166 -170.

    • Search Google Scholar
  • Giustina, A., Barkan, A., Casanueva, F. F. és mtsai: Criteria for cure of acromegaly: a consensus statement. J. Clin. Endocrinol. Metab., 2000, 85, 526–529.

    Casanueva F. F. , 'Criteria for cure of acromegaly: a consensus statement ' (2000 ) 85 J. Clin. Endocrinol. Metab. : 526 -529.

    • Search Google Scholar
  • Dénes J., Korbonits M., Hubina E. és mtsa: Az acromegalia kezelése. Orv. Hetil., 2010, 151, 1384–1393.

    Hubina E. , 'Az acromegalia kezelése ' (2010 ) 151 Orv. Hetil. : 1384 -1393.